Biotest AG
Biotest AG (BTTAY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BTTAY · as of Jun 8, 2026
Key Statistics
Explore Biotest AG Data
bttay stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bttay competitorsBTTAY
CKDXF
CLAZF
CSWYF
EBRCZ
IVEVFStock Performance
Full HistoryAbout Biotest AG
Biotest AG Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers…
what is biotest ag · bttay stock overview · biotest ag company profile · who is biotest ag ceo · bttay OTC · biotest ag headquarters · biotest ag business segments
About Stock Overview & Key Data
Biotest AG (BTTAY) is a Healthcare company in the Biotechnology industry, listed on OTC since Aug 8, 2022. As of the latest trading session, BTTAY stock price is $24.23, with a market capitalization of $943.0M. The stock has returned -0.16% over the past 12 months and -0.16% year-to-date.
In fiscal year 2024, Biotest AG reported revenue of $726.2M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Biotest AG (BTTAY) stock price is $24.23. The stock is traded on OTC under the ticker symbol BTTAY. The 52-week range is $22.80 – $24.27.